Nama Insights

vVARDIS (VVVV)

Healthcare · Medical Instruments Supplies · NYSE

vVARDIS (VVVV) is a Healthcare company in the Medical Instruments Supplies industry. It has a market capitalization of $2.72B and a free-cash-flow yield of -0.7%. Over the most recent reported fiscal year, revenue grew 148.5%. Nama's AI scorecard rates it Sell, 2.5 out of 10.
AI scorecard
Sell · 2.5/10
Clearly negative, short of the bottom band. As of Nov 20, 2026.
Shariah screen
Can't Tell
A figure the screen needs is missing, so it can't tell.
Off its high
-14.2%
How far the last close sits under the highest price of the past five years.
Market cap$2.72B
Trailing P/E—
Price / book—
Price / sales55.6
FCF yield-0.7%
Dividend yield—
Gross margin85.4%
Operating margin-68.9%
Net margin-105.2%
Revenue growth (YoY)+148.5%
Revenue growth (3-yr annual)—
EPS growth (YoY)—
FCF/share growth (YoY)—
Beta—
ExchangeNYSE
SectorHealthcare
IndustryMedical Instruments Supplies

Medical Instruments Supplies peers

TickerCompanyMarket capP/E
ISRG Intuitive Surgical $141.17B 37.6
BDX Becton, Dickinson $57.93B 16.1
MDLN Medline $49.80B 23.9
ALC Alcon $35.79B 22.0
RMD ResMed $33.32B 20.5
WST West Pharmaceutical Services $27.63B 43.1
SOLV Solventum $14.58B 12.2
BAX Baxter International $13.14B 13.1
Explore live VVVV data on Nama Insights →

VVVV FAQ

Is VVVV a buy?
Nama's AI scorecard currently rates vVARDIS Sell (2.5 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
Is VVVV Shariah compliant?
Nama's AAOIFI-style screen reads vVARDIS as Can't Tell. A figure the screen needs is missing, so it can't tell.